stockrowDianthus Therapeutics, Inc. (DNTH) vs Edgewise Therapeutics, Inc. (EWTX)
- Dianthus Therapeutics, Inc. DNTH 86.43 +4.12%
- Edgewise Therapeutics, Inc. EWTX 44.89 +15.49%
Dianthus Therapeutics, Inc. and Edgewise Therapeutics, Inc. are both Biotechnology companies. Dianthus Therapeutics, Inc. and Edgewise Therapeutics, Inc. are of similar size ($4.6B and $4.2B). Dianthus Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Edgewise Therapeutics, Inc. trades at 4.9×. Edgewise Therapeutics, Inc. has the higher net margin (0.00% vs −7,436.5%) and the higher return on invested capital (0.00% vs −36.6%). Across the 13 metrics below, Edgewise Therapeutics, Inc. leads on 9 and Dianthus Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | DNTH | EWTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 68.51% |
| Operating margin | (8,683.89%) | 0.00% | 0.00% |
| Net margin | (7,436.50%) | 0.00% | 0.00% |
| Free cash flow margin | (6,469.87%) | 0.00% | 0.00% |
| Return on equity | (22.61%) | 92.15% | (51.96%) |
| Return on assets | (21.81%) | 85.43% | (46.06%) |
| Return on invested capital | (36.55%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack